Christine Spitzweg, MD, is a Professor of Medicine and Endocrinology and Metabolism University Hospital of the Ludwig-Maximilians-University in Munich, Germany, with an adjunct academic appointment at the Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic Rochester, MN, USA.

She is an academic endocrinologist with a special focus on thyroid cancer and neuroendocrine tumors. Her research aims at investigation of the biology of the sodium iodide symporter (NIS) as a theranostic gene in and outside of the thyroid gland as well as regulation of the tumor microenvironment by thyroid hormones.

She has been a member and chair of the research committee (2007–2013) and a member of the Board of Directors of the American Thyroid Association (2014–2018), a member of the editorial board of THYROID (2013–2022), and is currently serving on the Board of Directors of the international Thyroid Oncology Group.

Co-Chair of the Society for Medical Oncology, Endocrine Tumors Working Group, German Cancer Society.
Member of the EORTC Endocrine Tumor Group (European Organization for Research and Treatment of Cancer).
Member of the ESE Thyroid Expert Group, European Society of Endocrinology.
Member of the Program Committee (Representative for Endocrinology, Neuroendocrinology, Diabetes and Metabolism) of the German Society for Internal Medicine.
Co-Chair of the Endo-ERN Thyroid Cancer Group (European Reference Network for Rare Endocrine Diseases).
Chairman of the EURACAN CCC Munich Endocrine Tumor Group.
Member of the Board of Directors of the International Thyroid Cancer Group.
Member of the Scientific Committee of the Working Group on Endocrine and Neuroendocrine Oncology of the German Endocrine Society.
2021 – Chair of the American Thyroid Association Program Committee.